Evidence map›Paper›PMID 28930204›Full record

ReviewMedicines (Basel, Switzerland)2015

Safety Analysis of

Young-Sook Kim, Jung-Yoon Woo, Chang-Kyun Han, Il-Moo Chang

Abstract readReview
In one paragraph

Review in Medicines (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Efficacy and Safety ofNutrients · 2024
    Trial
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Current View on How Human Gut Microbiota Mediate Metabolic and Pharmacological Activity ofEndocrine, metabolic & immune disorders drug targets · 2024
    Article
  14. Red ginseng aqueous extract improves mucociliary transport dysfunction and histopathology in CF rat airways.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Young-Sook KimThe Korea Ginseng Research Institute, Korea Ginseng Corporation, Daejeon 305-805, Korea. yskim@kgc.co.kr.
Jung-Yoon WooThe Korea Ginseng Research Institute, Korea Ginseng Corporation, Daejeon 305-805, Korea. 20130021@kgc.co.kr.
Chang-Kyun HanThe Korea Ginseng Research Institute, Korea Ginseng Corporation, Daejeon 305-805, Korea. ckhan@kgc.co.kr.
Il-Moo ChangThe Korea Ginseng Research Institute, Korea Ginseng Corporation, Daejeon 305-805, Korea. koginseng@kgc.co.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28930204
PMCPMC5533164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.